Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,026
Closed -$252K 738
2021
Q2
$252K Sell
1,026
-200
-16% -$52.5K 0.02% 634
2021
Q1
$324K Sell
1,226
-49
-4% -$13.8K 0.02% 576
2020
Q4
$374K Buy
1,275
+174
+16% +$44.6K 0.03% 492
2020
Q3
$260K Hold
1,101
0.03% 523
2020
Q2
$218K Buy
+1,101
New +$205K 0.02% 654
2019
Q4
Sell
-3,944
Closed -$507K 647
2019
Q3
$507K Buy
3,944
+100
+3% +$13K 0.05% 387
2019
Q2
$529K Buy
3,844
+38
+1% +$4.51K 0.06% 378
2019
Q1
$470K Sell
3,806
-1,403
-27% -$176K 0.05% 401
2018
Q4
$611K Sell
5,209
-1,822
-26% -$215K 0.05% 276
2018
Q3
$773K Buy
+7,031
New +$776K 0.06% 240

Other funds holding AMED

Cigna Investments's AMED Position: Q3 2021 in Review

Cigna Investments sold out of Amedisys (AMED) in Q3 2021, closing a stake of 1,026 shares — an estimated $252K sold.

Cigna Investments first reported a position in AMED in Q3 2018 and held it in 10 quarters. The position peaked at $773K in Q3 2018. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Cigna Investments reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • Cigna Investments sold 1,026 Amedisys shares in Q3 2021, an estimated $252K.
  • Cigna Investments first reported a position in Amedisys in Q3 2018 and held it in 10 quarters.
  • Cigna Investments's Amedisys position peaked at $773K in Q3 2018.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Cigna Investments's 13F filing for Q3 2021, filed 12 Nov 2021.